IQGAP1 interacts with MYL9 and acts on the ERK1/2 pathway to regulate cancer-associated fibroblasts (CAFs), which secrete CCL2 and TGF-β1, thereby influencing the tumor microenvironment and patient outcomes (80). This evidence concerns the gene IQGAP1 and cancer.